ERBB2 may play a role in protecting EGFR against ubiquitination, and our results suggest strong interactions between EGFR and ERBB2 in these EGFR-mutated lung cancer cells (Shtiegman et al, 2007). The gene discussed is ERBB2; the disease is lung carcinoma.